3
Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market
Ein Dokument
mehr
Storys zum Thema Biosimilar
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
Press release: STADA continues strong growth journey in the first half of 2024
Ein DokumentmehrPress release: STADA continues with double-digit sales and profit growth in 2023
Ein DokumentmehrLTS Lohmann Therapie-Systeme AG
First product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the US
mehr- 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
Ein Dokumentmehr
1